SDPR Inhibits TGF-β Induced Cancer Metastasis Through Fatty Acid Oxidation Regulation in Gastric Cancer

Int J Biol Sci. 2023 Jun 4;19(10):2999-3014. doi: 10.7150/ijbs.83012. eCollection 2023.

Abstract

Our previous studies have confirmed that transforming growth factor-β (TGF-β) plays an important role in tumor metastasis, and the serum deprivation protein response (SDPR) is a potential downstream target of TGF-β. However, the role and mechanism of SDPR in gastric cancer are still unclear. We performed gene microarray, bioinformation analysis, combined with in vivo and in vitro experimental verification, we identified that SDPR is significantly downregulated in gastric cancer, and participates in TGF-β-mediated tumour metastasis. Mechanically, SDPR interacts with extracellular signal-regulated kinase (ERK) and inhibits fatty acid metabolism key gene Carnitine palmitoyl transferase 1A (CPT1A) at transcriptional level by supressing ERK/PPAR pathway. Our findings suggest that the TGF-β/SDPR/CPT1A axis play an important role in the fatty acid oxidation of gastric cancer, and provides a new insight into the crosstalk of tumour microenvironments and metabolism reprogramming and suggest that strategies to intervene the fatty acid metabolism may therapy gastric cancer metastasis.

Keywords: CPT1A; SDPR; TGF-β; fatty acid oxidation; gastric cancer.

MeSH terms

  • Cell Line, Tumor
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Fatty Acids / metabolism
  • Humans
  • Lipid Metabolism
  • Stomach Neoplasms* / metabolism
  • Transforming Growth Factor beta / genetics
  • Transforming Growth Factor beta / metabolism
  • Tumor Microenvironment

Substances

  • Transforming Growth Factor beta
  • Extracellular Signal-Regulated MAP Kinases
  • Fatty Acids